• Senzime announced research presented at ANESTHESIOLOGY 2026 showing improved TetraGraph monitoring performance during deep neuromuscular block.
• The device's automated monitoring improved assessment of block depth and frequency compared with manual activation.
• A separate economic model estimated approximately $1.23 million in net annual savings from broader quantitative monitoring, with break-even in approximately 30 days.
• The modeled savings reflected fewer postoperative pulmonary complications in a hospital handling 4,000 relevant surgical cases annually.
• The economic research was scheduled for presentation on October 17, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Senzime AB published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202610171320ACCESSWRNAPR_____1238046) on October 17, 2026, and is solely responsible for the information contained therein.